{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06112340",
            "orgStudyIdInfo": {
                "id": "VGN-TED-302"
            },
            "organization": {
                "fullName": "Sling Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)",
            "officialTitle": "A Multicenter, Extension Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)",
            "therapeuticArea": [
                "Endocrinology",
                "Other"
            ],
            "study": "a-phase-extension-study-of-two-doses-of-linsitinib-in-subjects-with-active-moderate-to-severe-thyroid-eye-disease-ted"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2023-10-11",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-16",
            "studyFirstSubmitQcDate": "2023-10-31",
            "studyFirstPostDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-31",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sling Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The overall study objective is to continue to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of linsitinib in subjects who were enrolled in the prior VGN-TED-301 through Week 24. These subjects include VGN-TED-301 Week 24 proptosis non-responders or subjects who relapse during the Follow-Up Period of VGN-TED-301."
        },
        "conditionsModule": {
            "conditions": [
                "Thyroid Eye Disease",
                "Graves Orbitopathy",
                "Endocrine System Diseases",
                "Eye Diseases",
                "Thyroid Associated Ophthalmopathy",
                "Graves Ophthalmopathy",
                "Thyroid Diseases",
                "Orbital Diseases",
                "Proptosis",
                "IGF1R",
                "Exophthalmos",
                "Hashimoto"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 75,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Low Dose",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Active Arm Low Dose Linsitinib",
                    "interventionNames": [
                        "Drug: linsitinib"
                    ]
                },
                {
                    "label": "High Dose",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Active Arm High Dose Linsitinib",
                    "interventionNames": [
                        "Drug: linsitinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "linsitinib",
                    "description": "Study medication taken twice daily by mouth",
                    "armGroupLabels": [
                        "High Dose",
                        "Low Dose"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Subjects who are Proptosis Responders at Week 24",
                    "description": "Percentage of subjects with a \u2265 2 mm reduction of proptosis from baseline as determined by exophthalmometer",
                    "timeFrame": "24 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from Baseline in Proptosis to Week 24 (Study Eye)",
                    "description": "Change from baseline in reduction of proptosis from baseline as determined by exophthalmometer",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Percentage of Subjects who are Overall Responders at Week 24",
                    "description": "Percentage of Subjects with a response of \u2265 2 mm reduction of proptosis at Week 24 as determined by exophthalmometer",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Percentage of Subjects who are CAS Categorical Responders at Week 24 (Study Eye)",
                    "timeFrame": "24 weeks"
                },
                {
                    "measure": "Change from Baseline in the Graves' Ophthalmopathy Quality of Life (GO-QoL) Questionnaire Overall Score to Week 24",
                    "timeFrame": "24 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject who completed the 24-week double-mask period of VGN-TED-301 and are proptosis non-responders (\\< 2 mm reduction in proptosis in the study eye) at Week 24 of VGN-TED-301 study or proptosis responders at Week 24 who relapse during the Follow-Up period of VGN-TED-301\n* Subject has not received any treatment for TED since Week 24 of VGN-TED-301\n* Subjects must be euthyroid with the participant's baseline disease under control or have mild hypo- or hyperthyroidism (defined as free thyroxine \\[FT4\\] and free triiodothyronine levels \\[FT3\\] \\<50% above or below the normal limits) at Baseline. Every effort should be made to correct mild hypo- or hyperthyroidism promptly and maintain the euthyroid state for the duration of the clinical trial\n* Does not require immediate ophthalmic surgery, radiotherapy to orbits or other ophthalmological intervention at the time of Baseline and is not planning for any such treatment during the course of the study\n\nExclusion Criteria:\n\n* The exclusion criteria of protocol VGN-TED-301 also apply to this extension study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Cathy Radovich",
                    "role": "CONTACT",
                    "phone": "734-887-9192",
                    "email": "info@slingtx.com"
                },
                {
                    "name": "Robin Schmidt",
                    "role": "CONTACT",
                    "phone": "734-887-9192",
                    "email": "info@slingtx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Bascom Palmer Eye Institute",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Gomez",
                            "role": "CONTACT",
                            "email": "jxg1540@miami.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "West Virginia University Eye Institute",
                    "status": "RECRUITING",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26506",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Athena Echols",
                            "role": "CONTACT",
                            "email": "athena.sparks@wvumedicine.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000049970",
                    "term": "Graves Ophthalmopathy"
                },
                {
                    "id": "D000005094",
                    "term": "Exophthalmos"
                },
                {
                    "id": "D000009916",
                    "term": "Orbital Diseases"
                },
                {
                    "id": "D000013959",
                    "term": "Thyroid Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "ancestors": [
                {
                    "id": "D000015785",
                    "term": "Eye Diseases, Hereditary"
                },
                {
                    "id": "D000006111",
                    "term": "Graves Disease"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000006042",
                    "term": "Goiter"
                },
                {
                    "id": "D000006980",
                    "term": "Hyperthyroidism"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "asFound": "Thyroid",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "asFound": "Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26148",
                    "name": "Graves Ophthalmopathy",
                    "asFound": "Thyroid Eye Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "asFound": "Endocrine System Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26156",
                    "name": "Hashimoto Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M12845",
                    "name": "Orbital Diseases",
                    "asFound": "Orbital Diseases",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8237",
                    "name": "Exophthalmos",
                    "asFound": "Exophthalmos",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18339",
                    "name": "Eye Diseases, Hereditary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9214",
                    "name": "Graves Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M9147",
                    "name": "Goiter",
                    "relevance": "LOW"
                },
                {
                    "id": "M10031",
                    "name": "Hyperthyroidism",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3542",
                    "name": "Lymphomatous Thyroiditis",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}